Filing Flows

Filing Flows › Companies › Innospec › Cash flow

Innospec cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$1.6M in Q3 2026 · $45.6M over twelve months

Operating cash flow$17.4M
Capital spending−$15.8M
Free cash flow+$1.6M
Cash / net income0.6×
Cash conversion cycle127 days

Analysis

In Q3 2026, Innospec generated $17.4M of operating cash flow and spent $15.8M on capital projects, leaving free cash flow of $1.6M. That is $23.2M less than in Q3 2025 ($24.8M).

Over the twelve months to Sep 30, 2026, operating cash flow was $103M; the largest uses were capital spending ($57.0M), dividends ($44.3M), buybacks ($13.5M); besides operations, cash came from asset & business sales ($2.4M), other financing ($1.9M); the cash balance fell by $18.9M.

Operating cash flow was $17.4M against net income of $31.6M — 0.6× profit, less cash than reported earnings, worth checking against working capital. The largest differences: inventory −$25.9M, payables −$15.4M, receivables +$11.6M.

Its cash conversion cycle was 127 days (receivables 78 + inventory 93 − payables 45).

Free cash flow

Innospec: free cash flow by quarterInnospec: free cash flow by quarter$13.6MQ4 2024$19.9MQ1 2025−$2.5MQ2 2025$24.8MQ3 2025$45.8MQ4 2025$8.7MQ1 2026−$10.5MQ2 2026$1.6MQ3 2026
Operating cash flow less capital spending.
Innospec: operating cash flow against capital spendingInnospec: operating cash flow against capital spendingOperating cash flowCapital spending$25.7M$12.1MQ4 2024$28.3M$8.4MQ1 2025$10.5M$13.0MQ2 2025$39.1M$14.3MQ3 2025$60.4M$14.6MQ4 2025$17.6M$8.9MQ1 2026$7.2M$17.7MQ2 2026$17.4M$15.8MQ3 2026
Latest (Q3 2026): Operating cash flow $17.4M, Capital spending $15.8M.

Capital allocation, year by year

Innospec: where the cash came from (up) and went (down), by fiscal yearInnospec: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $93.2MFY2021: Net borrowing −$1.1MFY2021: Shares issued $10.1MFY2021: Asset sales $2.9MFY2021: Capital spending −$39.1MFY2021: Buybacks −$800KFY2021: Dividends −$28.8M$106MFY2021FY2022: Operating cash flow $81.7MFY2022: Net borrowing −$200KFY2022: Shares issued $2.2MFY2022: Asset sales $200KFY2022: Capital spending −$39.6MFY2022: Buybacks −$5.9MFY2022: Dividends −$31.7M$84.1MFY2022FY2023: Operating cash flow $207MFY2023: Net borrowing −$2.3MFY2023: Shares issued $900KFY2023: Asset sales $100KFY2023: Capital spending −$62.1MFY2023: Acquisitions −$34.7MFY2023: Buybacks −$1.1MFY2023: Dividends −$35.1M$208MFY2023FY2024: Operating cash flow $184MFY2024: Shares issued $2.1MFY2024: Asset sales $500KFY2024: Capital spending −$41.4MFY2024: Acquisitions −$200KFY2024: Buybacks −$700KFY2024: Dividends −$38.8M$187MFY2024FY2025: Operating cash flow $138MFY2025: Shares issued $500KFY2025: Asset sales $1.1MFY2025: Capital spending −$50.3MFY2025: Acquisitions −$700KFY2025: Buybacks −$23.9MFY2025: Dividends −$42.4M$140MFY2025
Over these 5 years operating cash flow totalled $705M; the largest uses were capital spending ($232M) and dividends ($177M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$252M
Debtnone
Net cash$252M

Innospec funds itself: free cash flow was $45.6M over the last twelve months, with $252M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Innospec: sources (+) and uses (−) of cash, Q3 2026Innospec: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$17.4MCapital spending−$15.8MCash drawn (+) / kept (−)−$1.7MAsset & business sales$200KExchange rates−$200KShares issued$100K
Innospec: sources (+) and uses (−) of cash, TTM to Q3 2026Innospec: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$103MCapital spending−$57.0MDividends−$44.3MCash drawn (+) / kept (−)$18.9MBuybacks−$13.5MOther investing−$11.7MAsset & business sales$2.4MOther financing$1.9MAcquisitions$1.3MExchange rates−$900KShares issued$300K

From profit to cash

Innospec: net income to operating cash flow, Q3 2026Innospec: net income to operating cash flow, Q3 2026Net income$31.6MDepreciation & amortization$9.6MStock-based pay$1.4MDeferred taxes−$300KReceivables$11.6MInventory−$25.9MPayables−$15.4MPrepaid and other assets$3.2MIncome taxes payable$4.6MOther operating capital−$1.0MOperating cash flow$17.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 2026789345127
Q2 2026718540116
Q1 2026698943115
Q4 2025709547117
Q3 2025719644124
Q2 2025709446118
Q1 2025708848110
Q4 2024668646106

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksDividendsShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$17.4M−$15.8M———$100K−$1.7M$1.6M
Q2 2026$7.2M−$17.7M—−$6.4M——$38.9M−$10.5M
Q1 2026$17.6M−$8.9M—−$7.1M—$100K$3.4M$8.7M
Q4 2025$60.4M−$14.6M$1.3M—−$21.6M$100K−$21.7M$45.8M
Q3 2025$39.1M−$14.3M−$2.0M−$10.6M——−$4.2M$24.8M
Q2 2025$10.5M−$13.0M—−$8.5M—$200K$33.2M−$2.5M
Q1 2025$28.3M−$8.4M—−$4.8M—$200K−$10.6M$19.9M
Q4 2024$25.7M−$12.1M——−$19.8M$1.3M$14.6M$13.6M

Innospec: income statement and cash flow

Innospec, Q3 2026: revenue $474M (+7% year over year), operating margin 8.8%. The chart follows the revenue to costs, profit and cash.

Innospec: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.